News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MANHARD KIMBERLY
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 149,365 rights
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $3.76, valued at
$7.6k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| MANHARD KIMBERLY (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Granted 15,000 options to buy
@ $12.57, valued at
$188.6k
|
|
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2022 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $6.07, valued at
$12.2k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 01/14/2022 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $8.3, valued at
$16.7k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 433 shares
@ $10.55, valued at
$4.6k
Exercised 1,250 restricted stock units
@ $0
Granted 92,200 options to buy
@ $10.55, valued at
$972.7k
Granted 55,320 restricted stock units
@ $0 |
|
| 07/15/2021 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 433 shares
@ $13.48, valued at
$5.8k
Exercised 1,250 restricted stock units
@ $0 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 10,000 shares
@ $20, valued at
$200k
Exercised 10,000 options to buy
@ $13, valued at
$130k
|
|
| 10/15/2020 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 120,000 options to buy
@ $15.72, valued at
$1.9M
Granted 20,000 restricted stock units
@ $0 |
|
| 08/21/2020 |
4
| MANHARD KIMBERLY (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Granted 17,259 options to buy
@ $17, valued at
$293.4k
|
|
| 05/01/2020 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 1,158 shares
@ $12.121, valued at
$14k
Sold 1,158 shares
@ $13.9687, valued at
$16.2k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 24,000 shares
@ $26, valued at
$624k
Exercised 24,000 options to buy
@ $13, valued at
$312k
|
|
| 05/02/2019 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 1,109 shares
@ $18.428, valued at
$20.4k
Sold 1,109 shares
@ $18.8621, valued at
$20.9k
|
|
| 12/18/2018 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 100,000 options to buy
@ $24.97, valued at
$2.5M
|
|
| 11/02/2018 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 494 shares
@ $23.596, valued at
$11.7k
Sold 494 shares
@ $30.6173, valued at
$15.1k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 5,900 shares
@ $37.5074, valued at
$221.3k
Sold 100 shares
@ $38.85, valued at
$3.9k
Exercised 6,000 options to buy
@ $13, valued at
$78k
|
|
| 03/19/2018 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 18,000 shares
@ $30, valued at
$540k
Exercised 18,000 options to buy
@ $13, valued at
$234k
|
|
| 01/12/2018 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 7,584 shares
@ $20, valued at
$151.7k
Exercised 7,584 options to buy
@ $13, valued at
$98.6k
|
|
| 12/20/2017 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 120,000 options to buy
@ $17, valued at
$2M
|
|
| 04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/29/2016 |
4
| MANHARD KIMBERLY (Executive VP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 300,000 options to buy
@ $20.69, valued at
$6.2M
|
|
| 12/24/2015 |
4
| MANHARD KIMBERLY (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 19,000 options to buy
@ $29.41, valued at
$558.8k
|
|
|
|
|